{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T11:23:12Z","timestamp":1772623392794,"version":"3.50.1"},"reference-count":112,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.fertnstert.2022.04.015","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T16:12:35Z","timestamp":1653322355000},"page":"1144-1159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evidence for the effectiveness of immunologic therapies in women with subfertility and\/or undergoing assisted reproduction"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-6107","authenticated-orcid":false,"given":"Pedro","family":"Melo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-5723","authenticated-orcid":false,"given":"Ingrid","family":"Granne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2022.04.015_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.fertnstert.2019.07.1346","article-title":"Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial","volume":"112","author":"Munne","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/humrep\/deaa317","article-title":"Definition, diagnostic and therapeutic options in recurrent implantation failure: an international survey of clinicians and embryologists","volume":"36","author":"Cimadomo","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05938.x","article-title":"Inflammation and pregnancy: the role of the immune system at the implantation site","volume":"1221","author":"Mor","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal-fetal interface in humans","volume":"563","author":"Vento-Tormo","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.607669","article-title":"How do uterine natural killer and innate lymphoid cells contribute to successful pregnancy?","volume":"12","author":"Huhn","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib6","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/humrep\/der104","article-title":"Measurements of CD56+ cells in peripheral blood and endometrium by flow cytometry and immunohistochemical staining in situ","volume":"26","author":"Laird","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/humupd\/dmt056","article-title":"Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis","volume":"20","author":"Seshadri","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0897.2007.00565.x","article-title":"Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer","volume":"59","author":"Kalu","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13429","article-title":"Increasing number of implantation failures and pregnancy losses associated with elevated Th1\/Th2 cell ratio","volume":"86","author":"Kuroda","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib11","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fimmu.2020.01032","article-title":"Endometrial immune profiling: a method to design personalized care in assisted reproductive medicine","volume":"11","author":"Ledee","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12016-016-8586-z","article-title":"Female infertility and serum auto-antibodies: a systematic review","volume":"53","author":"Deroux","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib13","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.fertnstert.2019.10.011","article-title":"In\u00a0vitro fertilization add-ons for the endometrium: it doesn't add-up","volume":"112","author":"Lensen","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humrep\/dex004","article-title":"Adjuncts in the IVF laboratory: where is the evidence for 'add-on' interventions?","volume":"32","author":"Harper","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib15","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/humrep\/deab098","article-title":"How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients","volume":"36","author":"Lensen","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047307","article-title":"VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia","volume":"11","author":"Armstrong","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/humrep\/den489","article-title":"Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF\/ICSI: a randomized, placebo-controlled, double-blind study","volume":"24","author":"Haapsamo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0015-0282(99)00088-6","article-title":"Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in\u00a0vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay","volume":"71","author":"Rubinstein","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.rbmo.2013.02.007","article-title":"Aspirin and heparin as adjuvants during IVF do not improve live birth rates in unexplained implantation failure","volume":"26","author":"Akhtar","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib22","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/humrep\/12.6.1171","article-title":"Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: role of heparin and aspirin","volume":"12","author":"Kutteh","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib23","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/oxfordjournals.humrep.a138437","article-title":"High fecundity rates following in-vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin","volume":"9","author":"Sher","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: a prospective cohort study","volume":"122","author":"Chen","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.fertnstert.2007.05.007","article-title":"Low-dose aspirin use does not improve in\u00a0vitro fertilization outcomes in poor responders","volume":"89","author":"Frattarelli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10815-014-0174-7","article-title":"Could empirical low-dose-aspirin administration during IVF cycle affect both the oocytes and embryos quality via COX 1-2 activity inhibition?","volume":"31","author":"Gizzo","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-1050-2-8","article-title":"Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in\u00a0vitro fertilization","volume":"2","author":"Hurst","year":"2005","journal-title":"J Exp Clin Assist Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1472-6483(10)61084-X","article-title":"Adjuvant therapy enhances endometrial receptivity in patients undergoing assisted reproduction","volume":"12","author":"Frattarelli","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/humrep\/den476","article-title":"Does low-dose aspirin improve pregnancy rate in IVF\/ICSI? A randomized double-blind placebo controlled trial","volume":"24","author":"Dirckx","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib30","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1093\/humrep\/deq286","article-title":"Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study","volume":"25","author":"Haapsamo","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2008.07.1759","article-title":"Low-dose aspirin in non-tubal IVF patients with previous failed conception: a prospective randomized double-blind placebo-controlled trial","volume":"92","author":"Lambers","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jog.13802","article-title":"Does low-dose aspirin improve pregnancy rate in women undergoing frozen-thawed embryo transfer cycle? A pilot double-blind, randomized placebo-controlled trial","volume":"45","author":"Madani","year":"2019","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1093\/humrep\/dei020","article-title":"Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF and ICSI patients: a randomized, placebo-controlled double-blind study","volume":"20","author":"Pakkila","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib34","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0015-0282(97)00330-0","article-title":"Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study","volume":"68","author":"Weckstein","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib35","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.7717\/peerj.691","article-title":"The physiologic and therapeutic role of heparin in implantation and placentation","volume":"3","author":"Quaranta","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1076029613501542","article-title":"Evaluation of 2 nomogram-based strategies for dosing argatroban in patients with known or suspected heparin-induced thrombocytopenia","volume":"21","author":"Arpino","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.placenta.2006.04.001","article-title":"Low-molecular weight heparin induces in\u00a0vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors","volume":"28","author":"Di Simone","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib38","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.fertnstert.2010.12.033","article-title":"The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study","volume":"95","author":"Berker","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib39","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/09513590.2018.1442426","article-title":"Administration of low-molecular-weight heparin in patients with two or more unsuccessful IVF\/ICSI cycles: a multicenter cohort study","volume":"34","author":"Siristatidis","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.rbmo.2011.03.016","article-title":"Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study","volume":"22","author":"Noci","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib41","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/14647270801995431","article-title":"Low-molecular-weight heparin in the treatment of recurrent IVF-ET failure and thrombophilia: a prospective randomized placebo-controlled trial","volume":"11","author":"Qublan","year":"2008","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib42","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/humrep\/dep086","article-title":"Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial","volume":"24","author":"Urman","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00404-013-3020-8","article-title":"Does combined prednisolone and low molecular weight heparin have a role in unexplained implantation failure?","volume":"289","author":"Fawzy","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/09513590.2017.1380182","article-title":"Administration of prednisolone and low molecular weight heparin in patients with repeated implantation failures: a cohort study","volume":"34","author":"Siristatidis","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jri.2018.03.003","article-title":"Impact of prednisone in patients with repeated embryo implantation failures: beneficial or deleterious?","volume":"127","author":"Ledee","year":"2018","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2018.10.001","article-title":"The effect of prednisolone on endometrial uterine NK cell concentrations and pregnancy outcome in women with reproductive failure. A retrospective cohort study","volume":"131","author":"Cooper","year":"2019","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4274\/tjod.12244","article-title":"A retrospective comparative study of prednisolone use in antagonist co-treated assisted reproductive technology cycles for patients with good prognosis","volume":"15","author":"Ozmen","year":"2018","journal-title":"Turk J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1023\/A:1020307227273","article-title":"Dexamethasone supplementation to gonadotropin stimulation for in\u00a0vitro fertilization in polycystic ovarian disease","volume":"16","author":"Bider","year":"1999","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib49","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0015-0282(16)58405-2","article-title":"Glucocorticoid administration during transfer of frozen-thawed embryos: a prospective, randomized study","volume":"66","author":"Bider","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib50","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0015-0282(16)57428-7","article-title":"Low-dose glucocorticoids after in\u00a0vitro fertilization and embryo transfer have no significant effect on pregnancy rate","volume":"63","author":"Moffitt","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/jog.12615","article-title":"In women with thyroid autoimmunity, does low-dose prednisolone administration, compared with no adjuvant therapy, improve in\u00a0vitro fertilization clinical results?","volume":"41","author":"Litwicka","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib52","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.clinthera.2011.01.010","article-title":"Preconception steroid treatment in infertile women with antithyroid autoimmunity undergoing ovarian stimulation and intrauterine insemination: a double-blind, randomized, prospective cohort study","volume":"32","author":"Turi","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0015-0282(98)00411-7","article-title":"Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial","volume":"71","author":"van Kasteren","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101369","article-title":"Infertility in women with systemic autoimmune diseases","volume":"33","author":"Khizroeva","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12958-020-00671-3","article-title":"Thyroid autoimmunity and IVF\/ICSI outcomes in euthyroid women: a systematic review and meta-analysis","volume":"18","author":"Venables","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib56","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.08.037","article-title":"Low-dose acetylsalicylic acid plus prednisolone as an adjuvant treatment in IVF: a prospective, randomized study","volume":"90","author":"Revelli","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib59","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2020.3937","article-title":"Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children","volume":"323","author":"R\u00e4ikk\u00f6nen","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2022.04.015_bib60","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/jmf.16.2.5.7","article-title":"Undesired effects of steroids during pregnancy","volume":"16","author":"Mariotti","year":"2004","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib61","first-page":"240","article-title":"The clinical use of corticosteroids in pregnancy","volume":"22","author":"Kemp","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101515","article-title":"the guardian of granulopoiesis","volume":"54","author":"Mehta","year":"2021","journal-title":"Semin Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102286","article-title":"Granulocyte-colony stimulating factor related pathways tested on an endometrial ex-vivo model","volume":"9","author":"Rahmati","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib64","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.fertnstert.2011.01.143","article-title":"Successful treatment of unresponsive thin endometrium","volume":"95","author":"Gleicher","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/19396368.2016.1251505","article-title":"Granulocyte colony stimulating factor treatment of resistant thin endometrium in women with frozen-thawed blastocyst transfer","volume":"63","author":"Kunicki","year":"2017","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.rbmo.2014.12.006","article-title":"Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles","volume":"30","author":"Xu","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib67","first-page":"341","article-title":"Effect of granulocyte colony stimulating factor (G-CSF) on IVF outcomes in infertile women: an RCT","volume":"14","author":"Eftekhar","year":"2016","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib68","first-page":"1","article-title":"The intrauterine perfusion of granulocyte-colony stimulating factor (G-CSF) before frozen-thawed embryo transfer in patients with two or more implantation failures","author":"Huang","year":"2020","journal-title":"Hum Fertil"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/jhrs.JHRS_20_18","article-title":"Effect of intrauterine perfusion of granulocyte colony-stimulating factor on endometrial parameters and in\u00a0vitro fertilization outcome in women undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection cycles: a randomized controlled trial","volume":"11","author":"Jain","year":"2018","journal-title":"J Hum Reprod Sci"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib70","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/s41598-020-61955-7","article-title":"Intrauterine G-CSF administration in recurrent implantation failure (RIF): an Rct","volume":"10","author":"Kalem","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ijgo.13152","article-title":"Therapeutic role of granulocyte macrophage colony-stimulating factor (GM-CSF) in patients with persistent thin endometrium: a prospective and randomized study","volume":"150","author":"Mao","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib72","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib73","first-page":"299","article-title":"Granulocyte-colony stimulating factor may improve pregnancy outcome in patients with history of unexplained recurrent implantation failure: an RCT","volume":"16","author":"Arefi","year":"2018","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib74","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.fertnstert.2013.12.016","article-title":"A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in\u00a0vitro fertilization cycles: impact on endometrial thickness and clinical pregnancy rates","volume":"101","author":"Barad","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib75","first-page":"661","article-title":"Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: a non-randomized clinical trial","volume":"12","author":"Eftekhar","year":"2014","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib76","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0897.2007.00473.x","article-title":"Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G","volume":"57","author":"Roussev","year":"2007","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib77","doi-asserted-by":"crossref","first-page":"e1328","DOI":"10.1002\/cti2.1328","article-title":"Effect of Intralipid infusion on peripheral blood T cells and plasma cytokines in women undergoing assisted reproduction treatment","volume":"10","author":"Foyle","year":"2021","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2019.06.007","article-title":"The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF\/ICSI with non-donor oocytes: a randomised controlled trial","volume":"240","author":"Singh","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/09513590.2019.1631280","article-title":"Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial","volume":"36","author":"Al-Zebeidi","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib80","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/15563650.2016.1151528","article-title":"Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration","volume":"54","author":"Hayes","year":"2016","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib81","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0897.2012.01135.x","article-title":"Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells","volume":"68","author":"Moraru","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib83","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0897.2008.00669.x","article-title":"Treatment with adalimumab (Humira) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF","volume":"61","author":"Winger","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib84","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/19396368.2017.1390007","article-title":"Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment","volume":"63","author":"Ahmadi","year":"2017","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib85","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.imlet.2015.12.010","article-title":"Multiple immune deviations predictive for IVF failure as possible markers for IVIG therapy","volume":"176","author":"Chernyshov","year":"2016","journal-title":"Immunol Lett"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib86","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fendo.2019.00937","article-title":"Peripheral CD56 + CD16 + NK cell populations in the early follicular phase are associated with successful clinical outcomes of intravenous immunoglobulin treatment in women with repeated implantation failure","volume":"10","author":"Ho","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0897.1998.tb00357.x","article-title":"The use of combined heparin\/aspirin and immunoglobulin G therapy in the treatment of in\u00a0vitro fertilization patients with antithyroid antibodies","volume":"39","author":"Sher","year":"1998","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib88","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0015-0282(00)01622-8","article-title":"Treatment of repeated unexplained in\u00a0vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial","volume":"74","author":"Stephenson","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib89","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/359076a0","article-title":"Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor","volume":"359","author":"Stewart","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib90","article-title":"LIF-STAT signaling and trophoblast biology","volume":"2","author":"Suman","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib91","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.fertnstert.2008.06.047","article-title":"Recombinant human leukemia inhibitory factor does not improve implantation and pregnancy outcomes after assisted reproductive techniques in women with recurrent unexplained implantation failure","volume":"91","author":"Brinsden","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib92","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.fertnstert.2021.10.025","article-title":"Novel therapeutic options for treatment of recurrent implantation failure","volume":"116","author":"Turocy","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib93","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jri.2011.07.001","article-title":"Intrauterine administration of autologous peripheral blood mononuclear cells increases clinical pregnancy rates in frozen\/thawed embryo transfer cycles of patients with repeated implantation failure","volume":"92","author":"Okitsu","year":"2011","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib94","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1093\/humrep\/del312","article-title":"Intrauterine administration of autologous peripheral blood mononuclear cells promotes implantation rates in patients with repeated failure of IVF-embryo transfer","volume":"21","author":"Yoshioka","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib95","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jri.2016.11.006","article-title":"Intrauterine administration of hCG-activated autologous human peripheral blood mononuclear cells (PBMC) promotes live birth rates in frozen\/thawed embryo transfer cycles of patients with repeated implantation failure","volume":"119","author":"Li","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103182","article-title":"Intrauterine administration of autologous hCG- activated peripheral blood mononuclear cells improves pregnancy outcomes in patients with recurrent implantation failure; a double-blind, randomized control trial study","volume":"142","author":"Pourmoghadam","year":"2020","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib97","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/aji.12542","article-title":"Intrauterine administration of autologous peripheral blood mononuclear cells (PBMCs) activated by HCG improves the implantation and pregnancy rates in patients with repeated implantation failure: a prospective randomized study","volume":"76","author":"Yu","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib98","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000484895","article-title":"Effect of etanercept on the success of assisted reproductive technology in patients with endometrioma","volume":"83","author":"Onalan","year":"2018","journal-title":"Gynecol Obstet Inves"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib99","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13378","article-title":"Inherited thrombophilia and anticoagulant therapy for women with reproductive failure","volume":"85","author":"Han","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib101","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2018.05.009","article-title":"The role of immunotherapy in in\u00a0vitro fertilization: a guideline","volume":"110","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib102","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14647273.2015.985454","article-title":"British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice","volume":"18","author":"Nardo","year":"2015","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib103","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.rbmo.2020.08.007","article-title":"Recurrent implantation failure in IVF: a Canadian Fertility and Andrology Society clinical practice guideline","volume":"41","author":"Shaulov","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.rbmo.2019.02.013","article-title":"Management of thin endometrium in assisted reproduction: a clinical practice guideline from the Canadian Fertility and Andrology Society","volume":"39","author":"Liu","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib105","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.fertnstert.2010.11.026","article-title":"Costs of infertility treatment: results from an 18-month prospective cohort study","volume":"95","author":"Katz","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib107","doi-asserted-by":"crossref","first-page":"31","DOI":"10.15171\/ajmb.2018.08","article-title":"The effects of subcutaneous administration of granulocyte colony-stimulating factor on pregnancy outcome after assisted reproductive technology: clinical trial","volume":"6","author":"Farimani","year":"2018","journal-title":"Avicenna J Med Biochem"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib108","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1111\/trf.14841","article-title":"Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin","volume":"58","author":"MacIsaac","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13395","article-title":"A systemic review of intravenous immunoglobulin G treatment in women with recurrent implantation failures and recurrent pregnancy losses","volume":"85","author":"Saab","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib110","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.fertnstert.2021.06.045","article-title":"A new definition of recurrent implantation failure on the basis of anticipated blastocyst aneuploidy rates across female age","volume":"116","author":"Ata","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib111","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41588-021-00972-2","article-title":"Mapping the temporal and spatial dynamics of the human endometrium in\u00a0vivo and in\u00a0vitro","volume":"53","author":"Garcia-Alonso","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib112","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41467-019-14123-z","article-title":"Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy","volume":"11","author":"Huhn","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.fertnstert.2022.04.015_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755624","article-title":"ERAP, KIR, and HLA-C profile in recurrent implantation failure","volume":"12","author":"Piekarska","year":"2021","journal-title":"Front Immunol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222002564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028222002564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:32:59Z","timestamp":1758011579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028222002564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":112,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0015028222002564"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.04.015","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for the effectiveness of immunologic therapies in women with subfertility and\/or undergoing assisted reproduction","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2022.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92022 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}